Financhill
Sell
27

CTEV Quote, Financials, Valuation and Earnings

Last price:
$14.50
Seasonality move :
10.95%
Day range:
$12.52 - $14.63
52-week range:
$12.04 - $74.07
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.23x
P/B ratio:
56.70x
Volume:
453.9K
Avg. volume:
226.3K
1-year change:
-41.81%
Market cap:
$222.6M
Revenue:
$965.4M
EPS (TTM):
-$17.30

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CTEV
Claritev Corp.
$241.2M $0.85 3.14% -93.41% $44.75
DRIO
DarioHealth Corp.
$5M -$1.59 -24.79% -245.23% $18.00
MITI
Mitesco, Inc.
-- -- -- -- --
NRC
National Research Corp.
-- -- -- -- --
SPOK
Spok Holdings, Inc.
$34.6M $0.24 -3.57% 18.18% $14.00
VASO
Vaso Corp.
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CTEV
Claritev Corp.
$13.47 $44.75 $222.6M -- $0.00 0% 0.23x
DRIO
DarioHealth Corp.
$11.97 $18.00 $80.9M -- $0.00 0% 6.64x
MITI
Mitesco, Inc.
$0.09 -- $1.4M 2.30x $0.00 0% 20.53x
NRC
National Research Corp.
$13.41 -- $303.6M 26.48x $0.16 3.88% 2.19x
SPOK
Spok Holdings, Inc.
$12.14 $14.00 $250.1M 15.93x $0.31 10.3% 1.81x
VASO
Vaso Corp.
$0.18 -- $32.2M 12.44x $0.00 0% 0.36x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CTEV
Claritev Corp.
103.92% 5.359 647.24% 0.60x
DRIO
DarioHealth Corp.
29.69% 1.433 75.99% 3.72x
MITI
Mitesco, Inc.
-156.54% 2.860 275.98% 0.00x
NRC
National Research Corp.
84.96% 2.674 19.45% 0.42x
SPOK
Spok Holdings, Inc.
4.53% 1.373 2.55% 0.99x
VASO
Vaso Corp.
6.71% -0.913 9.7% 1.77x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CTEV
Claritev Corp.
$64.7M $1.3M -6.21% -1037.49% 0.53% $36.4M
DRIO
DarioHealth Corp.
$3M -$9.5M -28.66% -41.55% -189.42% -$7.4M
MITI
Mitesco, Inc.
-$23.9K -$1M -- -- -33713.33% -$120.9K
NRC
National Research Corp.
$19.1M $4.7M 11.87% 51.49% 13.26% $6.1M
SPOK
Spok Holdings, Inc.
$25.3M $4.2M 10.03% 10.55% 12.26% $10.1M
VASO
Vaso Corp.
$13.9M $1.5M 8.84% 9.61% 6.79% $3M

Claritev Corp. vs. Competitors

  • Which has Higher Returns CTEV or DRIO?

    DarioHealth Corp. has a net margin of -32.68% compared to Claritev Corp.'s net margin of -41.48%. Claritev Corp.'s return on equity of -1037.49% beat DarioHealth Corp.'s return on equity of -41.55%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev Corp.
    26.25% -$4.88 $4.4B
    DRIO
    DarioHealth Corp.
    60.22% -$3.05 $106.6M
  • What do Analysts Say About CTEV or DRIO?

    Claritev Corp. has a consensus price target of $44.75, signalling upside risk potential of 232.22%. On the other hand DarioHealth Corp. has an analysts' consensus of $18.00 which suggests that it could grow by 50.38%. Given that Claritev Corp. has higher upside potential than DarioHealth Corp., analysts believe Claritev Corp. is more attractive than DarioHealth Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev Corp.
    2 1 0
    DRIO
    DarioHealth Corp.
    3 1 0
  • Is CTEV or DRIO More Risky?

    Claritev Corp. has a beta of 0.605, which suggesting that the stock is 39.49% less volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.081, suggesting its more volatile than the S&P 500 by 8.118%.

  • Which is a Better Dividend Stock CTEV or DRIO?

    Claritev Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Claritev Corp. pays -- of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or DRIO?

    Claritev Corp. quarterly revenues are $246.6M, which are larger than DarioHealth Corp. quarterly revenues of $5M. Claritev Corp.'s net income of -$80.6M is lower than DarioHealth Corp.'s net income of -$2.1M. Notably, Claritev Corp.'s price-to-earnings ratio is -- while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev Corp. is 0.23x versus 6.64x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev Corp.
    0.23x -- $246.6M -$80.6M
    DRIO
    DarioHealth Corp.
    6.64x -- $5M -$2.1M
  • Which has Higher Returns CTEV or MITI?

    Mitesco, Inc. has a net margin of -32.68% compared to Claritev Corp.'s net margin of -106766.67%. Claritev Corp.'s return on equity of -1037.49% beat Mitesco, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev Corp.
    26.25% -$4.88 $4.4B
    MITI
    Mitesco, Inc.
    -796.67% -$0.27 -$9.3M
  • What do Analysts Say About CTEV or MITI?

    Claritev Corp. has a consensus price target of $44.75, signalling upside risk potential of 232.22%. On the other hand Mitesco, Inc. has an analysts' consensus of -- which suggests that it could grow by 389.98%. Given that Mitesco, Inc. has higher upside potential than Claritev Corp., analysts believe Mitesco, Inc. is more attractive than Claritev Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev Corp.
    2 1 0
    MITI
    Mitesco, Inc.
    0 0 0
  • Is CTEV or MITI More Risky?

    Claritev Corp. has a beta of 0.605, which suggesting that the stock is 39.49% less volatile than S&P 500. In comparison Mitesco, Inc. has a beta of 5.491, suggesting its more volatile than the S&P 500 by 449.051%.

  • Which is a Better Dividend Stock CTEV or MITI?

    Claritev Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mitesco, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Claritev Corp. pays -- of its earnings as a dividend. Mitesco, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or MITI?

    Claritev Corp. quarterly revenues are $246.6M, which are larger than Mitesco, Inc. quarterly revenues of $3K. Claritev Corp.'s net income of -$80.6M is lower than Mitesco, Inc.'s net income of -$3.2M. Notably, Claritev Corp.'s price-to-earnings ratio is -- while Mitesco, Inc.'s PE ratio is 2.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev Corp. is 0.23x versus 20.53x for Mitesco, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev Corp.
    0.23x -- $246.6M -$80.6M
    MITI
    Mitesco, Inc.
    20.53x 2.30x $3K -$3.2M
  • Which has Higher Returns CTEV or NRC?

    National Research Corp. has a net margin of -32.68% compared to Claritev Corp.'s net margin of 5.11%. Claritev Corp.'s return on equity of -1037.49% beat National Research Corp.'s return on equity of 51.49%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev Corp.
    26.25% -$4.88 $4.4B
    NRC
    National Research Corp.
    54.31% $0.08 $93M
  • What do Analysts Say About CTEV or NRC?

    Claritev Corp. has a consensus price target of $44.75, signalling upside risk potential of 232.22%. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Claritev Corp. has higher upside potential than National Research Corp., analysts believe Claritev Corp. is more attractive than National Research Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev Corp.
    2 1 0
    NRC
    National Research Corp.
    0 0 0
  • Is CTEV or NRC More Risky?

    Claritev Corp. has a beta of 0.605, which suggesting that the stock is 39.49% less volatile than S&P 500. In comparison National Research Corp. has a beta of 0.528, suggesting its less volatile than the S&P 500 by 47.168%.

  • Which is a Better Dividend Stock CTEV or NRC?

    Claritev Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research Corp. offers a yield of 3.88% to investors and pays a quarterly dividend of $0.16 per share. Claritev Corp. pays -- of its earnings as a dividend. National Research Corp. pays out 100.39% of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or NRC?

    Claritev Corp. quarterly revenues are $246.6M, which are larger than National Research Corp. quarterly revenues of $35.2M. Claritev Corp.'s net income of -$80.6M is lower than National Research Corp.'s net income of $1.8M. Notably, Claritev Corp.'s price-to-earnings ratio is -- while National Research Corp.'s PE ratio is 26.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev Corp. is 0.23x versus 2.19x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev Corp.
    0.23x -- $246.6M -$80.6M
    NRC
    National Research Corp.
    2.19x 26.48x $35.2M $1.8M
  • Which has Higher Returns CTEV or SPOK?

    Spok Holdings, Inc. has a net margin of -32.68% compared to Claritev Corp.'s net margin of 8.65%. Claritev Corp.'s return on equity of -1037.49% beat Spok Holdings, Inc.'s return on equity of 10.55%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev Corp.
    26.25% -$4.88 $4.4B
    SPOK
    Spok Holdings, Inc.
    74.83% $0.14 $153.3M
  • What do Analysts Say About CTEV or SPOK?

    Claritev Corp. has a consensus price target of $44.75, signalling upside risk potential of 232.22%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $14.00 which suggests that it could grow by 15.32%. Given that Claritev Corp. has higher upside potential than Spok Holdings, Inc., analysts believe Claritev Corp. is more attractive than Spok Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev Corp.
    2 1 0
    SPOK
    Spok Holdings, Inc.
    0 1 0
  • Is CTEV or SPOK More Risky?

    Claritev Corp. has a beta of 0.605, which suggesting that the stock is 39.49% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.445, suggesting its less volatile than the S&P 500 by 55.51%.

  • Which is a Better Dividend Stock CTEV or SPOK?

    Claritev Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 10.3% to investors and pays a quarterly dividend of $0.31 per share. Claritev Corp. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 165.72% of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or SPOK?

    Claritev Corp. quarterly revenues are $246.6M, which are larger than Spok Holdings, Inc. quarterly revenues of $33.9M. Claritev Corp.'s net income of -$80.6M is lower than Spok Holdings, Inc.'s net income of $2.9M. Notably, Claritev Corp.'s price-to-earnings ratio is -- while Spok Holdings, Inc.'s PE ratio is 15.93x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev Corp. is 0.23x versus 1.81x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev Corp.
    0.23x -- $246.6M -$80.6M
    SPOK
    Spok Holdings, Inc.
    1.81x 15.93x $33.9M $2.9M
  • Which has Higher Returns CTEV or VASO?

    Vaso Corp. has a net margin of -32.68% compared to Claritev Corp.'s net margin of 7.55%. Claritev Corp.'s return on equity of -1037.49% beat Vaso Corp.'s return on equity of 9.61%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev Corp.
    26.25% -$4.88 $4.4B
    VASO
    Vaso Corp.
    61.33% $0.01 $30.3M
  • What do Analysts Say About CTEV or VASO?

    Claritev Corp. has a consensus price target of $44.75, signalling upside risk potential of 232.22%. On the other hand Vaso Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Claritev Corp. has higher upside potential than Vaso Corp., analysts believe Claritev Corp. is more attractive than Vaso Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev Corp.
    2 1 0
    VASO
    Vaso Corp.
    0 0 0
  • Is CTEV or VASO More Risky?

    Claritev Corp. has a beta of 0.605, which suggesting that the stock is 39.49% less volatile than S&P 500. In comparison Vaso Corp. has a beta of 0.458, suggesting its less volatile than the S&P 500 by 54.204%.

  • Which is a Better Dividend Stock CTEV or VASO?

    Claritev Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Vaso Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Claritev Corp. pays -- of its earnings as a dividend. Vaso Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or VASO?

    Claritev Corp. quarterly revenues are $246.6M, which are larger than Vaso Corp. quarterly revenues of $22.7M. Claritev Corp.'s net income of -$80.6M is lower than Vaso Corp.'s net income of $1.7M. Notably, Claritev Corp.'s price-to-earnings ratio is -- while Vaso Corp.'s PE ratio is 12.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev Corp. is 0.23x versus 0.36x for Vaso Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev Corp.
    0.23x -- $246.6M -$80.6M
    VASO
    Vaso Corp.
    0.36x 12.44x $22.7M $1.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
47
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 36x

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
54
AAOI alert for Mar 2

Applied Optoelectronics, Inc. [AAOI] is up 21.71% over the past day.

Buy
90
BNAI alert for Mar 2

Brand Engagement Network, Inc. [BNAI] is up 2.44% over the past day.

Sell
36
WLDN alert for Mar 2

Willdan Group, Inc. [WLDN] is down 1.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock